MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, J.
Right arrow Articles by el-Fakahany, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, J.
Right arrow Articles by el-Fakahany, E. E.

Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands

J Hu, SZ Wang, C Forray and EE el-Fakahany

Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Minneapolis 55455.

A large number of diverse pharmacological agents bind to a secondary domain on the muscarinic receptor, to influence allosterically the interaction of ligands at the primary binding site. Based on common structural features of these antagonists, we examined the interaction of protamine, an endogenous polycationic peptide, and of polyamines with muscarinic receptors in rat heart. Our results provide several lines of qualitative evidence that protamine allosterically modulates the conformation of muscarinic receptors, in a marked negatively cooperative manner. It decelerated the dissociation of N- [3H]methylscopolamine ([3H] NMS) initiated by atropine, in a concentration-dependent fashion. Inhibition by protamine of [3H]NMS binding at equilibrium showed a distinct plateau, which increased in magnitude at higher ligand concentrations. Scatchard analysis of saturation isotherms of [3H]NMS binding in the absence and presence of protamine indicated that protamine did not alter Bmax in a statistically significant fashion, although there was a trend of a concentration-dependent increase in this parameter. On the other hand, it caused a marked concentration-dependent decrease in the affinity of [3H]NMS, and this effect reached a ceiling limit. However, there were marked quantitative deviations of the interaction of protamine from a simple ternary allosteric model. Some of these discrepancies could be explained by the tendency of protamine to increase Bmax. The allosteric actions of protamine demonstrated in kinetic and equilibrium experiments were selective for m1 and m2 muscarinic receptors, compared with m3, m4, and m5 receptors, as studied in Chinese hamster ovary cells transfected with the genes of the different muscarinic receptors. Arginine residues play an important role in the allosteric interaction of protamine, inasmuch as poly-L-arginine qualitatively mimicked the effects of protamine. In contrast, no effects of the polyamines spermine, spermidine, and putrescine were observed on [3H]NMS binding. This is the first report on the allosteric modulation of muscarinic receptors by an endogenous peptide.

Volume 42, Issue 2, pp. 311-321, 08/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Durcan, R. W. Costello, W. G. McLean, J. Blusztajn, B. Madziar, A. G. Fenech, I. P. Hall, G. J. Gleich, L. McGarvey, and M.-T. Walsh
Eosinophil-Mediated Cholinergic Nerve Remodeling
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 775 - 786.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
K. A. Selz, A. J. Mandell, M. F. Shlesinger, V. Arcuragi, and M. J. Owens
Designing Human m1 Muscarinic Receptor-Targeted Hydrophobic Eigenmode Matched Peptides as Functional Modulators
Biophys. J., March 1, 2004; 86(3): 1308 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. M. Flacker and J. Y. Wei
Endogenous Anticholinergic Substances May Exist During Acute Illness in Elderly Medical Patients
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2001; 56(6): M353 - M355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. D. FRYER and D. B. JACOBY
Muscarinic Receptors and Control of Airway Smooth Muscle
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S154 - S160.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R W Costello, D B Jacoby, and A D Fryer
Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity
Thorax, July 1, 1998; 53(7): 613 - 618.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
S.-J. O, M. H. Cox, R. Mukherjee, M. J. Clair, F. A. Crawford Jr, and F. G. Spinale
Direct and Interactive Effects of Cardioplegic Arrest and Protamine on Myocyte Contractility
Ann. Thorac. Surg., August 1, 1996; 62(2): 489 - 494.
[Abstract] [Full Text]


Home page
CirculationHome page
R. B. Hird, T. W. Wakefield, R. Mukherjee, B. U. Jones, F. A. Crawford, P. C. Andrews, J. C. Stanley, and F. G. Spinale
Direct Effects of Protamine Sulfate on Myocyte Contractile Processes : Cellular and Molecular Mechanisms
Circulation, November 1, 1995; 92(9): 433 - 446.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. B. Hird, F. G. Spinale, K. W. Hewett, R. Mukherjee, and F. A. Crawford
The direct effects of protamine sulfate on myocyte contractile processes
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1100 - 1114.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics